Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Mack

Showing results (321-330 of 444) with videos related to

Pageof 45
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2018
The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer PatientsOliver A Zill, Kimberly C Banks, Stephen R Fairclough, et al.
Frontiers in Oncology|March 6, 2024
Precision needle-punch tumor enrichment from paraffin blocks improves the detection of clinically actionable genomic alterations and biomarkersDouglas I Lin, Richard S P Huang, Ioannis Ladas, et al.
Oncotarget|June 11, 2015
Identification of alsterpaullone as a novel small molecule inhibitor to target group 3 medulloblastomaClaudia C Faria, Sameer Agnihotri, Stephen C Mack, et al.
Science Translational Medicine|October 2, 2024
A peptide encoded by upstream open reading frame of <i>MYC</i> binds to tropomyosin receptor kinase B and promotes glioblastoma growth in miceFanying Li, Kailin Yang, Xinya Gao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2003
SU5416 plus interferon alpha in advanced renal cell carcinoma: a phase II California Cancer Consortium Study with biological and imaging correlates of angiogenesis inhibitionPrimo N Lara, David I Quinn, Kim Margolin, et al.
Stem Cells (Dayton, Ohio)|April 18, 2013
FoxG1 interacts with Bmi1 to regulate self-renewal and tumorigenicity of medulloblastoma stem cellsBranavan Manoranjan, Xin Wang, Robin M Hallett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2009
Japanese-US common-arm analysis of paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a model for assessing population-related pharmacogenomicsDavid R Gandara, Tomoya Kawaguchi, John Crowley, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 14, 2021
Lung Cancer and Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Identifying Important Knowledge Gaps for InvestigationChristian Rolfo, Noy Meshulami, Alessandro Russo, et al.
The Lancet. Oncology|July 23, 2013
Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trialDavid I Quinn, Catherine M Tangen, Maha Hussain, et al.
Clinical Lung Cancer|February 15, 2021
Phase 2 Study of Talazoparib in Patients With Homologous Recombination Repair-Deficient Squamous Cell Lung Cancer: Lung-MAP Substudy S1400GTaofeek K Owonikoko, Mary W Redman, Lauren A Byers, et al.
Pageof 45

Showing results (321-330 of 444) with videos related to

Sort By:
Pageof 45
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2018
The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer PatientsOliver A Zill, Kimberly C Banks, Stephen R Fairclough, et al.
Frontiers in Oncology|March 6, 2024
Precision needle-punch tumor enrichment from paraffin blocks improves the detection of clinically actionable genomic alterations and biomarkersDouglas I Lin, Richard S P Huang, Ioannis Ladas, et al.
Oncotarget|June 11, 2015
Identification of alsterpaullone as a novel small molecule inhibitor to target group 3 medulloblastomaClaudia C Faria, Sameer Agnihotri, Stephen C Mack, et al.
Science Translational Medicine|October 2, 2024
A peptide encoded by upstream open reading frame of <i>MYC</i> binds to tropomyosin receptor kinase B and promotes glioblastoma growth in miceFanying Li, Kailin Yang, Xinya Gao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2003
SU5416 plus interferon alpha in advanced renal cell carcinoma: a phase II California Cancer Consortium Study with biological and imaging correlates of angiogenesis inhibitionPrimo N Lara, David I Quinn, Kim Margolin, et al.
Stem Cells (Dayton, Ohio)|April 18, 2013
FoxG1 interacts with Bmi1 to regulate self-renewal and tumorigenicity of medulloblastoma stem cellsBranavan Manoranjan, Xin Wang, Robin M Hallett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2009
Japanese-US common-arm analysis of paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a model for assessing population-related pharmacogenomicsDavid R Gandara, Tomoya Kawaguchi, John Crowley, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 14, 2021
Lung Cancer and Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Identifying Important Knowledge Gaps for InvestigationChristian Rolfo, Noy Meshulami, Alessandro Russo, et al.
The Lancet. Oncology|July 23, 2013
Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trialDavid I Quinn, Catherine M Tangen, Maha Hussain, et al.
Clinical Lung Cancer|February 15, 2021
Phase 2 Study of Talazoparib in Patients With Homologous Recombination Repair-Deficient Squamous Cell Lung Cancer: Lung-MAP Substudy S1400GTaofeek K Owonikoko, Mary W Redman, Lauren A Byers, et al.
Pageof 45